Douglas Linfert

Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy

Jonathan Barratt, Richard Lafayette, Jens Kristensen et al. · Kidney International · 2022 · 205 citations · Full text

Transcriptional analysis of kidneys during repair from AKI reveals possible roles for NGAL and KIM-1 as biomarkers of AKI-to-CKD transition

Gang Jee Ko, Dmitry N. Grigoryev, Douglas Linfert et al. · American Journal of Physiology-Renal Physiology · 2010 · 203 citations

Ferric Citrate Controls Phosphorus and Delivers Iron in Patients on Dialysis

Julia B. Lewis, Mohammed Sika, Mark J. Koury et al. · Journal of the American Society of Nephrology · 2014 · 187 citations · Full text

Active Control Period, Hemodialysis, Urology +13

Myocardial Cell Death and Apoptosis in Hibernating Myocardium

Chunguang Chen, Lijie Ma, Douglas Linfert et al. · Journal of the American College of Cardiology · 1997 · 104 citations

Cardiac Muscle, Cardiomyopathy, Heart Failure +9

Prevalence of the C282Y and H63D polymorphisms in a multi-ethnic control population.

David Marshall, Douglas Linfert, Gregory J. Tsongalis · International Journal of Molecular Medicine · 1999 · 32 citations

Ethnicity, Genetic Testing, Genetics +17